Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
These are the Fastest Italian Sports Cars - 2Why the weirdest sea level changes on Earth are happening off the coast of Japan
- 32026 Golden Globes: How to watch, start time, TV channel, full nominee list and more
- 4Most loved Solace Food: What's Your Definitive Comfortable Dinner?
- 5One perk to marrying Richard Marx later in life? 'We don't have time' for stupid arguments, says Daisy Fuentes.
- The most effective method to Promoter for Cutthroat Medical attendant Compensations in Your Medical services Office
- ‘Grit’ and relentless perseverance can take a toll on brain health − particularly for people facing social stresses like racism
- Pain at the pump for Hampton Roads residents
- College students are now slightly less likely to experience severe depression, research shows – but the mental health crisis is far from over
- Deadly Switzerland ski resort fire was likely started by sparklers attached to champagne bottles, officials say
- Figure out How to Advance Space in Your Pre-assembled Home for Upgraded Usefulness
- Merz postpones Norway trip for Belgium talks on frozen Russian assets
- Figure out How to Plan for Your Web-based Degree monetarily
- France, Germany, Italy summon Iranian envoys over 'unbearable, inhumane' regime crackdown
